Chemotherapy for symptom control in recurrent squamous cell carcinoma of the head and neck
Open Access
- 1 May 1997
- journal article
- Published by Elsevier in Annals of Oncology
- Vol. 8 (5), 445-449
- https://doi.org/10.1023/a:1008203613364
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancerAnnals of Oncology, 1996
- An overview of randomised controlled trials of adjuvant chemotherapy in head and neck cancerBritish Journal of Cancer, 1995
- Lack of Survival Advantage in Patients with Advanced Squamous Cell Carcinomas of the Oral Cavity Receiving Neoadjuvant Chemotherapy Prior to Local Therapy, Despite Achieving an Initial High Clinical Complete Remission RateAmerican Journal of Clinical Oncology, 1994
- Adjuvant chemotherapy in head and neck cancerBritish Journal of Cancer, 1990
- A phase III randomised trial of cisplatinum, methotrextate, cisplatinum + methotrexate and cisplatinum + 5-FU in end stage squamous carcinoma of the head and neckBritish Journal of Cancer, 1990
- Symptom relief with moderate dose chemotherapy (mitomycin-C, vinblastine and cisplatin) in advanced non-small cell lung cancerBritish Journal of Cancer, 1989
- Mitomycin, ifosfamide and cis-platin in non-small cell lung cancer: treatment good enough to compareBritish Journal of Cancer, 1988
- Chemotherapy in Head and Neck CancerNew England Journal of Medicine, 1983
- World Health Organisation biomedical research guidelines and the conduct of clinical trials.Journal of Medical Ethics, 1980
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958